Immune Aging (Immunosenescence) The Next Major Target for Longevity Medicine

Immune Aging (Immunosenescence) The Next Major Target for Longevity Medicine Abstract The human immune system undergoes gradual decline with advancing age, a process termed immunosenescence. This deterioration represents one of the most promising targets for extending healthy lifespan. Research demonstrates that immune aging contributes to

Ageotypes and Modern Longevity Biomarkers: What Physicians Should Monitor Beyond Telomeres

Ageotypes and Modern Longevity Biomarkers: What Physicians Should Monitor Beyond Telomeres Key Takeaways Stanford's ageotypes framework revolutionizes aging assessment by identifying four distinct aging patterns—metabolic, immune, hepatic, and nephrotic—enabling personalized longevity interventions beyond traditional approaches. • Telomeres alone are insufficient: Individual variation and tissue-specific differences

Immune Aging (Immunosenescence) The Next Major Target for Longevity Medicine